Plasmid interference for curing antibiotic resistance plasmids in vivo.

Antibiotic resistance increases the likelihood of death from infection by common pathogens such as Escherichia coli and Klebsiella pneumoniae in developed and developing countries alike. Most important modern antibiotic resistance genes spread between such species on self-transmissible (conjugative)...

Full description

Bibliographic Details
Main Authors: Muhammad Kamruzzaman, Shereen Shoma, Christopher M Thomas, Sally R Partridge, Jonathan R Iredell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5330492?pdf=render
_version_ 1817986973621551104
author Muhammad Kamruzzaman
Shereen Shoma
Christopher M Thomas
Sally R Partridge
Jonathan R Iredell
author_facet Muhammad Kamruzzaman
Shereen Shoma
Christopher M Thomas
Sally R Partridge
Jonathan R Iredell
author_sort Muhammad Kamruzzaman
collection DOAJ
description Antibiotic resistance increases the likelihood of death from infection by common pathogens such as Escherichia coli and Klebsiella pneumoniae in developed and developing countries alike. Most important modern antibiotic resistance genes spread between such species on self-transmissible (conjugative) plasmids. These plasmids are traditionally grouped on the basis of replicon incompatibility (Inc), which prevents coexistence of related plasmids in the same cell. These plasmids also use post-segregational killing ('addiction') systems, which poison any bacterial cells that lose the addictive plasmid, to guarantee their own survival. This study demonstrates that plasmid incompatibilities and addiction systems can be exploited to achieve the safe and complete eradication of antibiotic resistance from bacteria in vitro and in the mouse gut. Conjugative 'interference plasmids' were constructed by specifically deleting toxin and antibiotic resistance genes from target plasmids. These interference plasmids efficiently cured the corresponding antibiotic resistant target plasmid from different Enterobacteriaceae in vitro and restored antibiotic susceptibility in vivo to all bacterial populations into which plasmid-mediated resistance had spread. This approach might allow eradication of emergent or established populations of resistance plasmids in individuals at risk of severe sepsis, enabling subsequent use of less toxic and/or more effective antibiotics than would otherwise be possible, if sepsis develops. The generalisability of this approach and its potential applications in bioremediation of animal and environmental microbiomes should now be systematically explored.
first_indexed 2024-04-14T00:16:05Z
format Article
id doaj.art-608e1c9cc0a34fe3b225ca7e5ebdd12d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T00:16:05Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-608e1c9cc0a34fe3b225ca7e5ebdd12d2022-12-22T02:23:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017291310.1371/journal.pone.0172913Plasmid interference for curing antibiotic resistance plasmids in vivo.Muhammad KamruzzamanShereen ShomaChristopher M ThomasSally R PartridgeJonathan R IredellAntibiotic resistance increases the likelihood of death from infection by common pathogens such as Escherichia coli and Klebsiella pneumoniae in developed and developing countries alike. Most important modern antibiotic resistance genes spread between such species on self-transmissible (conjugative) plasmids. These plasmids are traditionally grouped on the basis of replicon incompatibility (Inc), which prevents coexistence of related plasmids in the same cell. These plasmids also use post-segregational killing ('addiction') systems, which poison any bacterial cells that lose the addictive plasmid, to guarantee their own survival. This study demonstrates that plasmid incompatibilities and addiction systems can be exploited to achieve the safe and complete eradication of antibiotic resistance from bacteria in vitro and in the mouse gut. Conjugative 'interference plasmids' were constructed by specifically deleting toxin and antibiotic resistance genes from target plasmids. These interference plasmids efficiently cured the corresponding antibiotic resistant target plasmid from different Enterobacteriaceae in vitro and restored antibiotic susceptibility in vivo to all bacterial populations into which plasmid-mediated resistance had spread. This approach might allow eradication of emergent or established populations of resistance plasmids in individuals at risk of severe sepsis, enabling subsequent use of less toxic and/or more effective antibiotics than would otherwise be possible, if sepsis develops. The generalisability of this approach and its potential applications in bioremediation of animal and environmental microbiomes should now be systematically explored.http://europepmc.org/articles/PMC5330492?pdf=render
spellingShingle Muhammad Kamruzzaman
Shereen Shoma
Christopher M Thomas
Sally R Partridge
Jonathan R Iredell
Plasmid interference for curing antibiotic resistance plasmids in vivo.
PLoS ONE
title Plasmid interference for curing antibiotic resistance plasmids in vivo.
title_full Plasmid interference for curing antibiotic resistance plasmids in vivo.
title_fullStr Plasmid interference for curing antibiotic resistance plasmids in vivo.
title_full_unstemmed Plasmid interference for curing antibiotic resistance plasmids in vivo.
title_short Plasmid interference for curing antibiotic resistance plasmids in vivo.
title_sort plasmid interference for curing antibiotic resistance plasmids in vivo
url http://europepmc.org/articles/PMC5330492?pdf=render
work_keys_str_mv AT muhammadkamruzzaman plasmidinterferenceforcuringantibioticresistanceplasmidsinvivo
AT shereenshoma plasmidinterferenceforcuringantibioticresistanceplasmidsinvivo
AT christophermthomas plasmidinterferenceforcuringantibioticresistanceplasmidsinvivo
AT sallyrpartridge plasmidinterferenceforcuringantibioticresistanceplasmidsinvivo
AT jonathanriredell plasmidinterferenceforcuringantibioticresistanceplasmidsinvivo